Abstract
Pre-Use Post Sterilization Integrity Testing is implemented in sterile filtration applications by drug manufacturers using a risk-based approach with consideration of the stipulation in Eudralex volume 4, Annex 1, of the European Union Good Manufacturing Practice for Sterile Products′ which states that ″The integrity of the sterilizing filter should be verified before use″ (1). Within the bacterial retention test design, performed as part of the process-specific sterile filter validation, it is important to simulate the filtration process under evaluation as closely as possible. Worst-case conditions experienced by the process filter during routine use that may impact the process filters′ ability to produce a sterile effluent should be accounted for in the study. As performing pre-use post sterilization integrity testing introduces additional mechanical stress on the process filter and a new potential route for the introduction of bioburden into the process fluid flow path related to the filter wetting procedure, a risk-based bacterial retention test design incorporating a pre-use post sterilization integrity testing simulation phase, should be considered after a thorough evaluation of the process specific conditions. The risk assessment should include evaluation of process pre-use post sterilization integrity testing conditions including but not limited to the integrity test method and specifications, the wetting fluid type, the maximum allowable number of pre-use post sterilization integrity test repetitions as well as the permitted bioburden level of the pre-use post sterilization integrity testing wetting fluid. The outcome of the assessment provides a basis for the process specific bacterial retention test design. In the following we present our perspective on the topic as well as detailed insight into various aspects of pre-use post sterilization integrity testing simulation test design for consideration.
- Annex 1
- Bacterial Retention Testing
- PUPSIT
- PUPSIT simulation
- Sterile drug products
- Sterilizing grade filters
- Received June 20, 2024.
- Accepted April 15, 2025.
- Copyright © 2025, Parenteral Drug Association
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.